• Publications
  • Influence
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
BACKGROUND The use of warfarin reduces the rate of ischemic stroke in patients with atrial fibrillation but requires frequent monitoring and dose adjustment. Rivaroxaban, an oral factor Xa inhibitor,Expand
  • 4,440
  • 172
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
BACKGROUND Angiotensin-converting-enzyme (ACE) inhibitors such as captopril reduce mortality and cardiovascular morbidity among patients with myocardial infarction complicated by left ventricularExpand
  • 2,171
  • 64
Evaluating the yield of medical tests.
A method is presented for evaluating the amount of information a medical test provides about individual patients. Emphasis is placed on the role of a test in the evaluation of patients with a chronicExpand
  • 1,736
  • 64
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index).
To develop a brief, self-administered questionnaire that accurately measures functional capacity and assesses aspects of quality of life, 50 subjects undergoing exercise testing with measurement ofExpand
  • 1,166
  • 61
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
BACKGROUND The presence of coexisting conditions has a substantial effect on the outcome of acute myocardial infarction. Renal failure is associated with one of the highest risks, but the influenceExpand
  • 1,721
  • 59
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of
Board of Trustees in March 2002 and by the American Heart Association Science Advisory and Coordinating Committee in March 2002. When citing this document, the American College of Cardiology and theExpand
  • 790
  • 55
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
BACKGROUND Statin therapy reduces low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular events, but whether the addition of ezetimibe, a nonstatin drug that reducesExpand
  • 744
  • 55
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task
Angina/Non-ST-Elevation Myocardial Infarction : ACC/AHA 2007 Guidelines for the Management of Patients With Unstable ISSN: 1524-4539 Copyright © 2007 American Heart Association. All rights reserved.Expand
  • 2,050
  • 45
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
BACKGROUND Antithrombotic therapy with heparin plus aspirin reduces the rate of ischemic events in patients with unstable coronary artery disease. Low-molecular-weight heparin has a more predictableExpand
  • 1,379
  • 38